UnknownPhase 1NCT03018093

A Phase I Study Evaluating Safety and Efficacy of C-CAR011 Treatment in Adult Subjects With r/r CD19+B-ALL

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Shanghai AbelZeta Ltd.
Principal Investigator
Li Yu, MD
Chinese PLA General Hospital
Intervention
C-CAR-011(biological)
Enrollment
20 enrolled
Eligibility
14-75 years · All sexes
Timeline
20172018

Study locations (1)

Collaborators

Chinese PLA General Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03018093 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials